{"id":564,"date":"2022-04-20T14:45:56","date_gmt":"2022-04-20T12:45:56","guid":{"rendered":"http:\/\/localhost\/siteformation\/?page_id=110"},"modified":"2025-03-07T17:17:09","modified_gmt":"2025-03-07T16:17:09","slug":"accueil","status":"publish","type":"page","link":"https:\/\/inserm1193.universite-paris-saclay.fr\/en\/","title":{"rendered":"Home page"},"content":{"rendered":"

<\/p>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

From the director<\/strong><\/h3>\n\n\n\n

The joint research unit UMR-S 1193\/HEPAREG Inserm\/Paris-Saclay University <\/strong>was founded on January 1, 2015 through the merge of UMR-S 785 with the training and research unit EA4530.
On January 1, 2020, the unit expanded by merging with UMR-S 1174\/ICPH.
The research unit 1193\/HEPAREG is made up of five teams, bringing together scientists and clinicians with strong recognition and expertise in research fields ranging from liver transplantation to the development of therapeutic strategies against fulminant hepatitis and primary liver cancers .<\/p>\n\n\n\n

Pr Didier Samuel<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n

Research teams<\/strong><\/h3>\n\n\n\n
\n
\n
\n
TEAM 1<\/strong>
Therapeutic Innovations in Liver Disease and Liver Transplantation
Translational Research<\/strong>
Pr Didier SAMUEL
Dr Ama GASSAMA-DIAGNE
Pr Eric VIBERT
Dr Audrey COILLY<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
TEAM 2<\/strong>
Liver organoid bioconstruction
Modelling and signatures of liver\ndiseases<\/strong>
<\/strong>Dr Fran\u00e7ois LE NAOUR
Dr Anne DUBART-KUPPERSCHMITT

<\/strong><\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

<\/strong>

TEAM 3<\/strong>
Microbiota, inflammation and liver cancer<\/strong>
<\/strong>Pr Jamilla FAIVRE


<\/strong><\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n



TEAM 4<\/strong>
Biliary homeostasis and liver repair<\/strong>
<\/strong>Dr Thierry TORDJMANN


<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n



TEAM 5<\/strong>
Cellular and molecular mechanisms of stress adaptation<\/strong>
<\/strong>Pr Christian PO\u00dcS

<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n


<\/p>\n\n\n\n

Where to find us?<\/strong><\/h3>\n\n\n\n

The Hepato-Biliary Center at Paul Brousse Hospital, Villejuif<\/strong><\/h4>\n\n\n\n

The HBC hosts our research teams 1, 2 and 3<\/a>.
The goal of the CHB is to develop comprehensive care of patients with liver and\/or biliary diseases (hepatic diseases, portal hypertension, complex biliary lesions) by creating a real \"Liver Institute\" by gathering at the same place a team of surgeons, physicians, endoscopists, radiologists, anesthesiologists, resuscitators, researchers as well as techniques and means. This global care is done throughout the life of a patient according to the evolution of his disease and the different therapeutic or monitoring stages.<\/p>\n\n\n\n

\n
\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n\n
\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n\n
\n